Update: Clover Health Expects Average Number of Direct Contracting Lives in 2022 to Double from Current Levels
13 11월 2021 - 6:20AM
Today, Clover Health (NASDAQ: CLOV) (“Clover”), a technology
company committed to improving health equity for seniors, announced
that it expects total Lives under Clover Management to grow nearly
60% to over 200,000 in 2022. As previewed on Clover’s third quarter
2021 earnings call earlier this week, Clover had deferred
announcement of its projected Direct Contracting aligned lives
until receipt of an initial Direct Contracting alignment estimate
for 2022, which it received yesterday, and now expects its average
number of Direct Contracting aligned lives in 2022 to double from
current levels to 125,000.
The statements contained in this document are solely those of
the authors and do not necessarily reflect the views or policies of
CMS. The authors assume responsibility for the accuracy and
completeness of the information contained in this document.
About Clover Health: Clover Health (Nasdaq:
CLOV) is a next-generation risk-bearing organization aiming to
achieve health equity for all Americans. While our mission is to
improve every life, we particularly focus on seniors who have
historically lacked access to affordable high quality
healthcare.
We aim to provide great care, in a sustainable way, by having a
business model built around improving medical outcomes while
lowering avoidable costs. We do this while taking a holistic
approach to understanding the health needs and social risk factors
of those under our care. This strategy is underpinned by the
company’s proprietary software platform, the Clover Assistant,
which is designed to aggregate patient data from across the health
ecosystem to support clinical decision-making by presenting
physicians and other providers with real-time, personalized
recommendations at the point of care.
Making care more accessible is at the heart of our business, and
we believe patients should have the freedom to choose their
doctors. We offer two models of care: affordable Medicare Advantage
plans with extensive benefits; and care coordination for Original
Medicare beneficiaries through Direct Contracting. For both
programs, we provide primary care physicians with the Clover
Assistant and also make comprehensive home-based care available via
the Clover Home Care program.
With its corporate headquarters in Nashville, Clover’s workforce
is distributed around the U.S. and also includes a team of
world-class technologists based in Hong Kong. The company manages
care for Medicare beneficiaries in eleven states, including
Arizona, Georgia, Kansas, Mississippi, New Jersey, New York,
Pennsylvania, South Carolina, Tennessee, Texas and Vermont.
Forward-Looking Statements:This press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Forward-looking
statements include statements regarding Clover Health’s projected
lives under management. These statements are subject to known and
unknown risks, uncertainties and other factors that may cause our
actual results, levels of activity, performance or achievements to
differ materially from results expressed or implied in this press
release. Such risk factors include, but are not limited to, those
related to: Clover Health’s ability to increase the lifetime value
of enrollments and manage medical expenses; changes in CMS’s risk
adjustment payment system; challenges in expanding our member and
beneficiary base or into new markets; Clover Health’s exposure to
unfavorable changes in local benefit costs, reimbursement rates,
competition and economic conditions; the impact of litigation or
investigations; changes or developments in Medicare or the health
insurance system and laws and regulations governing the health
insurance markets; the current and future impact of the COVID-19
pandemic on Clover Health’s business and industry; the timing and
market acceptance of new releases and upgrades to the Clover
Assistant; programmatic changes and adjustments made to the Direct
Contracting Model; the successful development of Direct Contracting
and the degree to which our offerings gain market acceptance by
physicians; potential changes to certain model methodologies of the
CMS Innovation Center, including but not limited to, allowed
provider classes, beneficiary alignment, benchmark establishment,
risk score modeling, and CMS alignment rules; any difficulties
complying with existing as well as new regulatory requirements;
potential non-compliance with CMS requirements and other laws and
regulations, which could result in sanctions against us that
prevent us from, among other actions, marketing or enrolling in
existing markets or entering new markets; and any notification that
CMS intends to discontinue or alter the Direct Contracting Model or
our participation in the program in a significant manner.
Additional information concerning these and other risk factors is
contained in the Risk Factors section included in our Quarterly
Report on Form 10-Q for the quarter ended September 30, 2021, which
we filed with the Securities and Exchange Commission on November 9,
2021. Clover Health assumes no obligation, and does not intend, to
update these forward-looking statements as a result of future
events or developments.
Press Contact: Andrew
Still-Baxterpress@cloverhealth.com
Investor Relations:Derrick
Nuemaninvestors@cloverhealth.com
Clover Health Investments (NASDAQ:CLOVW)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Clover Health Investments (NASDAQ:CLOVW)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024